President Donald Trump will deliver his first major speech on drug prices on April 26; a recent Medicare Payment Advisory Commission proposal would cut Medicare payment rates by 30% for some services at hospital-affiliated free-standing emergency departments; nursing homes routinely turn away patients seeking care if they are using medication-assisted treatment to treat substance use disorder for opioids.
President Donald Trump will deliver his first major speech about drug prices on April 26, Politico reported. Based on his fiscal 2019 budget request, he could advocate for Medicare and Medicaid demonstrations to test new ways of paying for drugs on a smaller scale, like allowing some states to try negotiating drug costs in Medicaid. He is unlikely to call for the sort of actions he did when he was a candidate, like allowing the government to negotiate the cost of drugs for Medicare.
A recent Medicare Payment Advisory Commission (MedPAC) proposal would cut Medicare payment rates by 30% for some services at hospital-affiliated free-standing emergency departments (EDs) that are located within 6 miles of an on-campus hospital ED, Kaiser Health News reported. Free-standing EDs have been growing and now number more than 500. The proposal is spurred by concerns that MedPAC’s payment for services at these facilities is higher than it should be since the patients who visit them are sometimes not as severely injured or ill as those at hospital facilities.
Nursing homes routinely turn away patients seeking care if they are using medication-assisted treatment (MAT) to treat substance use disorder for opioids—a practice that legal experts say violates the Americans with Disabilities Act, STAT reported. After hospital discharge, many patients require further nursing care. But STAT has found that many nursing facilities refuse to accept such patients, often because of stigma, gaps in training, and the widespread misconception that abstinence is superior to medications for treating addiction. Nursing home staff may be unfamiliarity with MAT. Facilities may not have a clinician on staff licensed to prescribe buprenorphine and may be unaware that the patient’s primary care doctor often can continue to provide the medicine.
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Commonwealth Fund Report Details Pervasive Racial and Ethnic Disparities in US Health Care, Outcomes
April 18th 2024Using 25 health system performance indicators, the Commonwealth Fund 2024 State Health Disparities Report evaluated racial and ethnic disparities in health care and health outcomes both within and across US states and highlighted the urgent need for equitable health care policies and practices in the US.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen